KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CBLI
Delisted

Cleveland BioLabs Stock Price (Quote)

$0.240
+0.0060 (+2.56%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.499 Friday, 27th May 2022 CBLI stock ended at $0.240. This is 2.56% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 8.70% from a day low at $0.230 to a day high of $0.250.
90 days $0.202 $1.06
52 weeks $0.202 $7.10

Historical Cleveland BioLabs prices

Date Open High Low Close Volume
Jan 14, 2019 $1.57 $1.74 $1.32 $1.43 31 712
Jan 11, 2019 $1.30 $1.35 $1.30 $1.30 3 603
Jan 10, 2019 $1.30 $1.34 $1.30 $1.33 2 868
Jan 09, 2019 $1.21 $1.35 $1.21 $1.25 9 778
Jan 08, 2019 $1.37 $1.37 $1.06 $1.20 8 185
Jan 07, 2019 $1.34 $1.38 $1.28 $1.38 4 683
Jan 04, 2019 $1.27 $1.33 $1.26 $1.30 6 678
Jan 03, 2019 $1.34 $1.34 $1.17 $1.33 4 161
Jan 02, 2019 $1.00 $1.25 $1.00 $1.24 6 417
Dec 31, 2018 $1.10 $1.14 $1.01 $1.01 46 841
Dec 28, 2018 $1.15 $1.23 $1.08 $1.08 30 635
Dec 27, 2018 $1.29 $1.29 $1.15 $1.15 28 665
Dec 26, 2018 $1.41 $1.41 $1.30 $1.32 12 685
Dec 24, 2018 $1.45 $1.45 $1.08 $1.27 20 844
Dec 21, 2018 $1.57 $1.59 $1.46 $1.46 18 163
Dec 20, 2018 $1.59 $1.60 $1.55 $1.57 17 574
Dec 19, 2018 $1.67 $1.67 $1.59 $1.60 3 764
Dec 18, 2018 $1.63 $1.78 $1.62 $1.62 4 150
Dec 17, 2018 $1.72 $1.76 $1.60 $1.60 3 441
Dec 14, 2018 $1.71 $1.87 $1.71 $1.71 4 479
Dec 13, 2018 $1.81 $1.81 $1.81 $1.81 348
Dec 12, 2018 $1.81 $1.95 $1.80 $1.81 2 196
Dec 11, 2018 $1.81 $1.95 $1.81 $1.82 1 295
Dec 10, 2018 $1.95 $2.00 $1.79 $1.79 8 083
Dec 07, 2018 $2.02 $2.03 $1.98 $2.03 2 352
Click to get the best stock tips daily for free!

About Cleveland BioLabs

Cleveland BioLabs Cleveland BioLabs, Inc., a biopharmaceutical company, focuses on developing pharmaceuticals designed to address diseases with unmet medical need. Its lead drug candidate includes Entolimod, a Toll-like receptor 5 (TLR5) agonist, which is used for the prevention of death from acute radiation syndrome, and is used as an oncology drug. The company is also developing CBLB612, a pharmacologically optimized synthetic molecule that structurally mimics n... CBLI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT